Takeda Settles “Pay-for-Delay” Consumer Claims
Tokyo-based Takeda Pharmaceutical agreed to pay $1.85 million as a settlement with consumers who filed a lawsuit against the company for allegedly delaying the commercial release of a generic, cheaper version of the ADHD drug Intuniv.